Insulin resistance is an independent risk factor for CVD in patients with CKD, believed to be related to interruption of the intracellular insulin pathway that occurs as a result of increased angiotensin II, inflammation, metabolic acidosis, and uremic toxins [18]. This evidence concerns the gene INS and chronic kidney disease.